Cargando…
IL-1RAP, a Key Therapeutic Target in Cancer
Cancer is a major cause of death worldwide and especially in high- and upper-middle-income countries. Despite recent progress in cancer therapies, such as chimeric antigen receptor T (CAR-T) cells or antibody-drug conjugate (ADC), new targets expressed by the tumor cells need to be identified in ord...
Autores principales: | Frenay, Jame, Bellaye, Pierre-Simon, Oudot, Alexandra, Helbling, Alex, Petitot, Camille, Ferrand, Christophe, Collin, Bertrand, Dias, Alexandre M. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735758/ https://www.ncbi.nlm.nih.gov/pubmed/36499246 http://dx.doi.org/10.3390/ijms232314918 |
Ejemplares similares
-
[(18)F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [(18)F]FDG PET/CT approach
por: Tanguy, Julie, et al.
Publicado: (2021) -
Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic Hyperthermia
por: Dias, Alexandre M. M., et al.
Publicado: (2022) -
GARP: A Key Target to Evaluate Tumor Immunosuppressive Microenvironment
por: Bouchard, Alexanne, et al.
Publicado: (2021) -
Coated recombinant target protein helps explore IL-1RAP CAR T-cell functionality in vitro
por: Da Rocha, Mathieu Neto, et al.
Publicado: (2022) -
RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells
por: Bouquet, Lucie, et al.
Publicado: (2023)